NPCE icon

Neuropace

90 hedge funds and large institutions have $294M invested in Neuropace in 2025 Q1 according to their latest regulatory filings, with 34 funds opening new positions, 29 increasing their positions, 14 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed

more first-time investments, than exits

New positions opened: | Existing positions closed:

more call options, than puts

Call options by funds: $ | Put options by funds: $

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

more funds holding

Funds holding:

26% more capital invested

Capital invested by funds: $234M → $294M (+$60.6M)

3.59% more ownership

Funds ownership: 69.91%73.5% (+3.6%)

50% less funds holding in top 10

Funds holding in top 10: 21 (-1)

Holders
90
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$22K
Puts
$5K
Net Calls
Net Calls Change

Top Buyers

1 +$37.2M
2 +$19.8M
3 +$10.1M
4
AC
Armistice Capital
New York
+$7.02M
5
Deutsche Bank
Deutsche Bank
Germany
+$6.4M

Top Sellers

1 -$59M
2 -$6.67M
3 -$4.69M
4
NCM
Nantahala Capital Management
Connecticut
-$3.13M
5
Jane Street
Jane Street
New York
-$1.12M
Name Holding Trade Value Shares
Change
Change in
Stake
26
$1.44M
27
$1.23M
28
$792K
29
$677K
30
$637K
31
$590K
32
$567K
33
$552K
34
$538K
35
$505K
36
$482K
37
$473K
38
$421K
39
$399K
40
$383K
41
$374K
42
$343K
43
$341K
44
$320K
45
$312K
46
$306K
47
$301K
48
$291K
49
$283K
50
$274K